Monoamine Transporters: New Targets for Cocaine Abuse and CNS Diseases/Disorders Treatment

Summary This summary describes classes of compounds jointly designed, synthesized and evaluated through a collaboration between the laboratories of Professor Bertha K. Madras of Harvard Medical School and Dr. Peter C. Meltzer of Organix Inc., a private company in Woburn MA. The compounds target monoamine transporters, specifically the dopamine transporter (DAT) the serotonin transporter (SERT) and the norepinephrine transporter (NET), with various affinities and transporter selectivities.

Applications Compounds for treatment of neuropsychiatric disorders and cocaine addiction. For Further Information Please Contact the Director of Business Development Michal Preminger Email: [email protected] Telephone: (617) 432-0920

Inventor(s): Madras, Bertha

Type of Offer: Licensing



« More Medical Patents

---